Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans-Reference-Cited by-同舟云学术

Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans

Published:2015-02-19 Issue:3 Volume:17 Page:493-505
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Ruigrok Mitchel J. R.,de Lange Elizabeth C. M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1208/s12248-015-9724-x.pdf

Reference74 articles.

1. Potter WZ. New era for novel CNS drug development. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2012;37(1):278–80.

2. Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov. 2004;3(8):711–6.

3. de Lange ECM. The mastermind approach to CNS drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects. Fluids Barriers CNS. 2013;10(1):12.

4. Illum L. Is nose-to-brain transport of drugs in man a reality? J Pharm Pharmacol. 2004;56(1):3–17.

5. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood–brain barrier. Neurobiol Dis. 2010;37(1):13–25.

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reservoir-type intranasal implants for sustained release of risperidone: A potential alternative for long-term treatment of schizophrenia;Journal of Drug Delivery Science and Technology;2024-09

2. Nanocarriers-mediated nose-to-brain drug delivery: A novel approach for the management of Alzheimer’s disease;Journal of Drug Delivery Science and Technology;2024-09

3. Nanogel-mediated therapeutic delivery across blood-cerebrospinal fluid and blood-spinal cord barriers;Brain Disorders;2024-09

4. Pharmacokinetics of intranasal drugs, still a missed opportunity?;Xenobiotica;2024-08-08

5. Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges;Expert Opinion on Drug Delivery;2024-07-02